Comparative proteomic analysis of anti-benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-transformed and normal human bronchial epithelial G0/G1 cells

Chemico-Biological Interactions

Volumn 186, Issue 2, 2010, Pages 166-173

  Zhao, Peng ^a   Zhong, Weijian ^b   Ying, Xianping ^b   Yao, Biyun ^a   Yuan, Zhun ^a   Fu, Juanling ^a   Zhou, Zongcan ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Anti benzo(a)pyrene 7,8 dihydrodiol 9,10 epoxide (anti BPDE); Anti BPDE transformed cells; PCNA; Q TOF MS MS; TPD52; Two dimensional gel electrophoresis

Indexed keywords

ANTI BENZO[A]PYRENE 7,8 DIHYDRODIOL 9,10 OXIDE; CALMODULIN; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLINE; EUKARYOTIC TRANSLATION INITIATION FACTOR 6; INITIATION FACTOR; INITIATION FACTOR 5A; MYOSIN LIGHT CHAIN; MYOSIN LIGHT POLYPEPTIDE 6; NUCLEAR PROTEIN; NUCLEAR PROTEIN HCC1; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; PROHIBITIN; SORCIN; SUMO 2 PROTEIN; TUMOR PROTEIN; TUMOR PROTEIN D52; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; BRONCHUS MUCOSA; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL INVASION; CELL MIGRATION; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; TANDEM MASS SPECTROMETRY; UPREGULATION; WESTERN BLOTTING;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; BASE SEQUENCE; BRONCHI; CARCINOGENS; CELL LINE; CELL LINE, TRANSFORMED; CELL MOVEMENT; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPITHELIAL CELLS; G0 PHASE; G1 PHASE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN ARRAY ANALYSIS; PROTEOMICS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; UP-REGULATION;

EUKARYOTA;

EID: 77953543833     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.04.015     Document Type: Article

References (49)

1. US CDC/ATSDR. Toxicological profile for polycyclic aromatic hydrocarbons. http://www.atsdr.cdc.gov/toxprofiles/tp69.pdf.
2. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans; polynuclear aromatic compounds, part 1: chemical, environmental and experimental data, The International Agency for Research on Cancer 1998, Lyon, France; World Health Organization.
3. Smith L.E., Denissenko M.F., Bennett W.P., Li H., Amin S., Tang M., Pfeifer G.P. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J. Natl. Cancer Inst. 2000, 2:803-811.
4. Mori I. Cancer mortality among man-made graphite electrode manufacturing workers: results of a 38 year follow up. Occup. Environ. Med. 2002, 59:473-480.
5. Friesen M.C., Demers P.A., Spinelli J.J., Lorenzi M.F., Le N.D. Comparison of two indices of exposure to polycyclic aromatic hydrocarbons in a retrospective aluminium smelter cohort. Occup. Environ. Med. 2007, 64:273-278.
6. Edwards B.K., Brown M.L., Wingo P.A., Howe H.L., Ward E., Ries L.A., Schrag D., Jamison P.M., Jemal A., Wu X.C., Friedman C., Harlan L., Warren J., Anderson R.N., Pickle L.W. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J. Natl. Cancer Inst. 2005, 97:1407-1427.
7. Kikuchi T., Carbone D.P. Proteomics analysis in lung cancer: challenges and opportunities. Respirology 2007, 12:22-28.
8. Oh S., Im H., Oh E., Lee J., Khim J.Y., Mun J., Kim Y., Lee E., Kim J., Sul D. Effects of benzo(a)pyrene on protein expression in Jurkat T-cells. Proteomics 2004, 4:3514-3526.
9. Gao Z., Jin J., Yang J., Yu Y. Zinc finger proteins and other transcription regulators as response proteins in benzo[a]pyrene exposed cells. Mutat. Res. 2004, 550:11-24.
10. Shen W., Liu H., Yu Y. Proteomic analysis of cellular responses to different concentrations of anti-benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide in human amniotic epithelial FL cells. J. Proteome Res. 2007, 6:4737-4748.
11. Li C., Xiao Z., Chen Z., Zhang X., Li J., Wu X., Li X., Yi H., Li M., Zhu G., Liang S. Proteome analysis of human lung squamous carcinoma. Proteomics 2006, 6:547-558.
12. Jiang Y., Chen J., Chen X. Malignant transformation of human bronchial epithelial cells induced by benzo(a)pyrene metabolite dihydroxyepoxy benzopyrene. Wei Sheng Yan Jiu 2001, 30:129-131.
13. Zhang L., Huang H., Deng L., Chu M., Xu L., Fu J., Zhu Y., Zhang X., Liu S., Zhou Z., Wang Y. TPX2 in malignantly transformed human bronchial epithelial cells by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide. Toxicology 2008, 252:49-55.
14. Zhao P., Zhong W., Ying X., Yuan Z., Fu J., Zhou Z. Manganese chloride-induced G0/G1 and S phase arrest in A549 cells. Toxicology 2008, 250:39-46.
15. Lee W.J., Wu L.F., Chen W.K., Wang C.J., Tseng T.H. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Chem. Biol. Interact. 2006, 160:123-133.
16. Cooper S., Shedden K. Microarray analysis of gene expression during the cell cycle. Cell Chromosome 2003, 2:1.
17. Shedden K., Cooper S. Analysis of cell-cycle-specific gene expression in human cells as determined by microarrays and double-thymidine block synchronization. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:4379-4384.
18. Whitfield M.L., Sherlock G., Saldanha A.J., Murray J.I., Ball C.A., Alexander K.E., Matese J.C., Perou C.M., Hurt M.M., Brown P.O., Botstein D. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 2002, 13:1977-2000.
19. Moldovan G.L., Pfander B., Jentsch S. PCNA, the maestro of the replication fork. Cell 2007, 129:665-679.
20. Sancar A., Lindsey-Boltz L.A., Unsal-Kaçmaz K., Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 2004, 73:39-85.
21. Scott M., Bonnefin P., Vieyra D., Boisvert F.M., Young D., Bazett-Jones D.P., Riabowol K. UV-induced binding of ING1 to PCNA regulates the induction of apoptosis. J. Cell Sci. 2001, 114:3455-3462.
22. Fujise K., Zhang D., Liu J., Yeh E.T. Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen. J. Biol. Chem. 2000, 275:39458-39465.
23. Dirim A., Haberal A.N., Goren M.R., Tekin M.I., Peskircioglu L., Demirhan B., Ozkardes H. VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value. Int. Urol. Nephrol. 2008, 40:861-868.
24. Prelich G., Tan C.K., Kostura M., Mathews M.B., So A.G., Downey K.M., Stillman B. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 1987, 326:517-520.
25. Mathews M.B., Bernstein R.M., Franza B.R., Garrels J.I. Identity of the proliferating cell nuclear antigen and cyclin. Nature 1984, 309:374-376.
26. Zheng M., Tian X., Li H., Cheng Y., Chen X. Expression of PCNA and the count of AgNOR in squamous cell carcinoma of larynx and hypopharynx. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2002, 16:653-655.
27. Shen L.J., Zhang H.X., Zhang Z.J., Li J.Y., Chen M.Q., Yang W.B., Huang R. Detection of HBV, PCNA and GST-pi in hepatocellular carcinoma and chronic liver diseases. World J. Gastroenterol. 2003, 9:459-462.
28. Kayaselçuk F., Zorludemir S., Gümürdühü D., Zeren H., Erman T. PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade. J. Neurooncol. 2002, 57:115-121.
29. Shang S., Takai N., Nishida M., Miyazaki T., Nasu K., Miyakawa I. CaMKIV expression is associated with clinical stage and PCNA-labeling index in endometrial carcinoma. Int. J. Mol. Med. 2003, 11:181-186.
30. Bhattacharyya N.K., Chatterjee U., Sarkar S., Kundu A.K. A study of proliferative activity, angiogenesis and nuclear grading in renal cell carcinoma. Indian J. Pathol. Microbiol. 2008, 51:17-21.
31. Byrne J.A., Tomasetto C., Garnier J.M., Rouyer N., Mattei M.G., Bellocq J.P., Rio M.C., Basset P. A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence. Cancer Res. 1995, 55:2896-2903.
32. Chen S.L., Maroulakou I.G., Green J.E., Romano-Spica V., Modi W., Lautenberger J., Bhat N.K. Isolation and characterization of a novel gene expressed in multiple cancers. Oncogene 1996, 12:741-751.
33. Garber M.E., Troyanskaya O.G., Schluens K., Petersen S., Thaesler Z., Pacyna-Gengelbach M., van de Rijn M., Rosen G.D., Perou C.M., Whyte R.I., Altman R.B., Brown P.O., Botstein D., Petersen I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13784-13789.
34. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., Ladd C., Beheshti J., Bueno R., Gillette M., Loda M., Weber G., Mark E.J., Lander E.S., Wong W., Johnson B.E., Golub T.R., Sugarbaker D.J., Meyerson M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13790-13795.
35. Rhodes D.R., Barrette T.R., Rubin M.A., Ghosh D., Chinnaiyan A.M. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res. 2002, 62:4427-4433.
36. Best C.J., Leiva I.M., Chuaqui R.F., Gillespie J.W., Duray P.H., Murgai M., Zhao Y., Simon R., Kang J.J., Green J.E., Bostwick D.G., Linehan W.M., Emmert-Buck M.R. Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis. Diagn. Mol. Pathol. 2003, 12:63-70.
37. Rubin M.A., Varambally S., Beroukhim R., Tomlins S.A., Rhodes D.R., Paris P.L., Hofer M.D., Storz-Schweizer M., Kuefer R., Fletcher J.A., His B.L., Byrne J.A., Pienta K.J., Collins C., Sellers W.R., Chinnaiyan A.M. Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Cancer Res. 2004, 64:3814-3822.
38. Wang R., Xu J., Saramäki O., Visakorpi T., Sutherland W.M., Zhou J., Sen B., Lim S.D., Mabjeesh N., Amin M., Dong J.T., Petros J.A., Nelson P.S., Marshall F.F., Zhau H.E., Chung L.W. PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer. Cancer Res. 2004, 64:1589-1594.
39. Chen X., Cheung S.T., So S., Fan S.T., Barry C., Higgins J., Lai K.M., Ji J., Dudoit S., Ng I.O., Van De Rijn M., Botstein D., Brown P.O. Gene expression patterns in human liver cancers. Mol. Biol. Cell 2002, 13:1929-1939.
40. Lewis J.D., Payton L.A., Whitford J.G., Byrne J.A., Smith D.I., Yang L., Bright R.K. Induction of tumorigenesis and metastasis by the murine orthologue of tumor protein D52. Mol. Cancer Res. 2007, 5:133-144.
41. Ummanni R., Teller S., Junker H., Zimmermann U., Venz S., Scharf C., Giebel J., Walther R. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells. FEBS J. 2008, 275:5703-5713.
42. Leaw C.L., Ren E.C., Choong M.L. Hcc-1 is a novel component of the nuclear matrix with growth inhibitory function. Cell. Mol. Life Sci. 2004, 61:2264-2273.
43. Choong M.L., Tan L.K., Lo S.L., Ren E.C., Ou K., Ong S.E., Liang R.C., Seow T.K., Chung M.C. An integrated approach in the discovery and characterization of a novel nuclear protein over-expressed in liver and pancreatic tumors. FEBS Lett. 2001, 496:109-116.
44. Fukuda S., Wu D.W., Stark K., Pelus L.M. Cloning and characterization of a proliferation-associated cytokine-inducible protein, CIP29. Biochem. Biophys. Res. Commun. 2002, 292:593-600.
45. Czarnecka A.M., Campanella C., Zummo G., Cappello F. Mitochondrial chaperones in cancer: from molecular biology to clinical diagnostics. Cancer Biol. Ther. 2006, 5:714-720.
46. Mishra S., Murphy L.C., Murphy L.J. The Prohibitins: emerging roles in diverse functions. J. Cell. Mol. Med. 2006, 10:353-363.
47. Nijtmans L.G., Artal S.M., Grivell L.A., Coates P.J. The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell. Mol. Life Sci. 2002, 59:143-155.
48. Coates P.J., Nenutil R., McGregor A., Picksley S.M., Crouch D.H., Hall P.A., Wright E.G. Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exp. Cell Res. 2001, 265:262-273.
49. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2001, 100:57-70.